Technical Data
Apolipoprotein E,E2,E3,E4 (Apo E,E2,E3,E4)
Suitable for use in Western Blot, ELISA, Immunoprecipitation and Immunohistochemistry. Other applications have not been tested.

Recommended Dilutions:
Western Blot: 1:1000-1:10,000
Immunohistochemistry (Frozen, FFPE): 1:1000-1:10,000
The staining intensity of formalin-fixed paraffin embedded tissues may be significantly improved by the pretreatment of:
1. Formic acid (70%) for 10-30 minutes at RT.
2. HIER (Heat Induced Epitope Retrieval) with buffers such as citrate.
Optimal dilutions to be determined by the researcher.


Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
MabIgG12B16Affinity Purified
100ul-20°CBlue IceHumanMouse
Synthetic peptide spanning the polymorphic aa position 158 of Apo E.
Purified by Protein A affinity chromatography.
Supplied as a liquid in PBS, pH 7.2. No preservative added.
Recognizes human Apo E. Recognizes E2, E3 and E4 isoforms of apolipoprotein E. Does not react with mouse and rabbit.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Norman, R.R., et al., “Apolipoprotein E genotyping in Alzheimer’s Disease”, Ann. N.Y. Acad. Science, 801 (Reviews). 2. Munoz, D.G., et al., (2000), CMAJ, 162(1): 65–72. 3. Tomiyama, T., et al., (1999),Cell Mol. Life Sci., 6(3-4): 268–279. 4. Hagberg, J.M., et al., (2000), Physiol. Genomics, 4(2): 101-–108. 5. Saunders, A.M., (2000), J. Neuropathol. Exp. Neurol., 59(9): 751–758. 6. Golabek, A.A., et al., (2000), Biophys. J. 79(2): 1008–1015. 7. Golabek, A.A., et al., (1996), J. Biol. Chem., 271(18): 10602–10606. 8. Zunarelli, E., et al., (2000), Breast Cancer Res. Treat, 63(3): 193–198. 9. Zunarelli, E., et al., (2000), Clin Neuropathol., 19(1): 1–6.